Elastrin Therapeutics Announces Newly Formed Scientific Advisory Board
Press release content from Business Wire. The AP news staff was not involved in its creation.
Stay updated with breaking news from Elastrin Therapeutics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Press release content from Business Wire. The AP news staff was not involved in its creation.
Elastrin Therapeutics Inc., a privately held biotechnology company leveraging a platform technology to develop therapeutics that render calcified tissue and organs supple again, announced the formation
(0) Elastrin Therapeutics Inc., a privately held biotechnology company leveraging a platform technology to develop therapeutics that render calcified tissue and organs supple again, announced the appointment of Pedro M. Quintana Diez, MD as Chief Medical Officer. Pedro will be responsible for the clinical and regulatory strategy, planning, and execution of the company's clinical development plans. "We are delighted to bring someone with Pedro's impressive expertise and experience on board during this exciting time for Elastrin," said Dr. Matthias Breugelmans, CEO at Elastrin Therapeutics. "Hi...